Buchumschlag

Looking beyond the origin of SARS-CoV-2: Significant strategic aspects during the five-year journey of COVID-19 vaccine development.

Fuente: PubMed

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Chakraborty, Chiranjib, Lo, Yi-Hao, Bhattacharya, Manojit, Das, Arpita, Wen, Zhi-Hong
Format:	Artículo científico
Sprache:	en
Veröffentlicht:	Molecular therapy. Nucleic acids 2025
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Deep learning in next-generation vaccine development for infectious diseases.
von: Bhattacharya, Manojit, et al.
Veröffentlicht: (2025)

Regulatory role of miRNAs in the human immune and inflammatory response during the infection of SARS‐CoV‐2 and other respiratory viruses: A comprehensive review
von: Chiranjib Chakraborty, et al.
Veröffentlicht: (2024)

Regulation of miRNA in Cytokine Storm (CS) of COVID‐19 and Other Viral Infection: An Exhaustive Review
von: Chiranjib Chakraborty, et al.
Veröffentlicht: (2025)

Understanding the landscape of cross-species transmission, epidemiology, phylogenetics, and antigenicity of HPAI strain A(H5N1) causing a recent outbreak in the USA.
von: Chakraborty, Chiranjib, et al.
Veröffentlicht: (2025)

Quercetin, Isoquercitrin, and Quercetin‐3‐Rutinoside: Understanding the Pharmacological, Organoleptic, ADME Properties, Human Health Toxicity, Ecological Risk, and Cosmetic Risk of Using Integrative Bioinformatics
von: Anirban Debnath, et al.
Veröffentlicht: (2025)

Autoantibodies in COVID‐19 and Other Viral Diseases: Molecular, Cellular, and Clinical Perspectives
von: Srijan Chatterjee, et al.
Veröffentlicht: (2024)

Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
von: Deborah L Burnett, et al.
Veröffentlicht: (2026)

The discovery, origins and evolution of SARS-CoV-2 (COVID-19)
von: Holmes, Edward C
Veröffentlicht: (2021)

Safety and immunogenicity of vaccines against SARS-CoV-2
von: Francisco Xavier Poveda Paredes
Veröffentlicht: (2021)

Comprehensive global-scale evaluation of the COVID-19 pandemic associated with 234 countries, territories, and sub-national locations during 2020-2024.
von: Chakraborty, Chiranjib, et al.
Veröffentlicht: (2025)

Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination
von: Nicole L Messina, et al.
Veröffentlicht: (2025)

Monte Carlo simulation of SARS-CoV-2 radiation-induced inactivation for vaccine development
von: Francis, Ziad, et al.
Veröffentlicht: (2020)

Phylogeography of horseshoe bat sarbecoviruses in Vietnam and neighbouring countries. Implications for the origins of SARS ‐ CoV and SARS ‐ CoV ‐2
von: Alexandre Hassanin, et al.
Veröffentlicht: (2024)

An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
von: Josef Finsterer
Veröffentlicht: (2024)

Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID ‐19 vaccination
von: Ilya Kister, et al.
Veröffentlicht: (2024)

Serological response to SARS‐CoV‐2 vaccination in patients with immunobullous diseases
von: B. Levian, et al.
Veröffentlicht: (2024)

Nationwide estimates of SARS‐CoV‐2 infection fatality rates and numbers needed to vaccinate for COVID‐19 vaccines in 2024 in Austria
von: Uwe Riedmann, et al.
Veröffentlicht: (2025)

Influenza vaccination on SARS‐CoV‐2 infection risk: A subgroup analysis on geographic factor
von: Kuo‐Chuan Hung, et al.
Veröffentlicht: (2024)

The characteristics of BCR‐CDR3 repertoire in COVID‐19 patients and SARS‐CoV‐2 vaccinated volunteers
von: Jiaping Xiao, et al.
Veröffentlicht: (2024)

COVID-19 y SARS-CoV-2
von: Alfredo Pinzón-Junca
Veröffentlicht: (2020)

Subacute thyroiditis after SARS‐CoV‐2 vaccination: A case report
von: Ozra Akha, et al.
Veröffentlicht: (2024)

Lung damage in SARS ‐ CoV ‐2 patients: An autopsy study in the era of vaccination
von: Rossana Bussani, et al.
Veröffentlicht: (2024)

Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination
von: Andrea Pilotto, et al.
Veröffentlicht: (2024)

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV
von: Liu, Jia, et al.
Veröffentlicht: (2020)

Mortality due to COVID-19 during the vaccination plan against the SARS-CoV-2 virus in Cali, Colombia
von: Carlos Reina
Veröffentlicht: (2021)

Response to COVID‐19 vaccination in patients on cancer therapy: Analysis in a SARS‐CoV‐2‐naïve population
von: George Cavic, et al.
Veröffentlicht: (2024)

Efficacy and safety of four COVID-19 vaccines in preventing SARS-CoV-2 infection: A rapid review
von: Lina Sofía Morón-Duarte
Veröffentlicht: (2022)

Evaluation of the therapeutic action of original antiviral drug in SARS‐CoV‐2
von: Arthur K. Melkonian, et al.
Veröffentlicht: (2024)

Current Topics in SARS-CoV-2/COVID-19
Veröffentlicht: (2023)

Correction to ‘Lung damage in SARS ‐ CoV ‐2 patients: An autopsy study in the era of vaccination’
Veröffentlicht: (2025)

Incremental immunogenicity of multiple doses of SARS‐CoV‐2 vaccination in patients with haematological malignancies
von: Abi Vijenthira, et al.
Veröffentlicht: (2025)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
von: Swapna Thomas, et al.
Veröffentlicht: (2024)

SARS‐CoV‐2 nucleocapsid antigen in plasma of children hospitalized for COVID‐19 or with incidental detection of SARS‐CoV‐2 infection
von: Nicolas Capelli, et al.
Veröffentlicht: (2024)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
von: Kuldeep Singh Patel
Veröffentlicht: (2020)

Effect of COVID 19 vaccination on the CT severity score for SARS CoV2 pneumonia- an experience from the initial wave
von: R. Batra
Veröffentlicht: (2023)

Preexisting symptoms increase the risk of developing long COVID during the SARS‐CoV‐2 pandemic
von: Vincent Lak, et al.
Veröffentlicht: (2025)

Torsional twist of the SARS ‐ CoV and SARS ‐ CoV ‐2 SUD ‐N and SUD ‐M domains
von: Monica Rosas‐Lemus, et al.
Veröffentlicht: (2025)

Biological characteristics of SARS-CoV-2 variants of epidemiological interest and their impact on vaccine efficacy and effectiveness.
von: Torres, Carolina, et al.
Veröffentlicht: (2021)

PLGA‐particle‐based vaccine induces SARS‐CoV‐2‐specific antibody and T‐cell responses
von: Dennis Horvath, et al.
Veröffentlicht: (2026)

Patient‐reported daily functioning after SARS‐CoV‐2 vaccinations in autoimmune neuromuscular diseases
von: Koos P. J. van Dam, et al.
Veröffentlicht: (2024)